Hvilken er prisen på Miravant Medical Technologies Inc. (MRVT)

Prisen på Miravant Medical Technologies Inc. (MRVT) er $0.00001

Hva er markedsverdien på Miravant Medical Technologies Inc. (MRVT)

Markedsverdien på Miravant Medical Technologies Inc. (MRVT) er $352.62

Miravant Medical Technologies Inc. (MRVT) P/S-forhold

Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light. Furthermore, the company manufactures the essential light-generating and light-delivery devices required for this treatment. Miravant's product pipeline includes several therapeutic agents: PHOTREX, which is aimed at treating wet age-related macular degeneration (AMD); MV9411, a photoreactive compound developed for managing plaque psoriasis; MV0633, which targets conditions like atherosclerosis, vulnerable atherosclerotic plaque, and restenosis; MV2101, designed to address vascular access graft disease in hemodialysis patients; and MV6401, a treatment under development for solid tumors. The organization, originally established as PDT, Inc., officially adopted its current name, Miravant Medical Technologies Inc., in September of 1997. Founded in 1989, it maintains its corporate headquarters in Santa Barbara, California.

År	P/S-forhold	Endre
Ikke nok data for de angitte datoene.

År

P/S-forhold

Endre

Ikke nok data for de angitte datoene.

Selskap	P/S-forhold	Forskjell i P/S-forhold	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	8.17	-	IN

Selskap

P/S-forhold

Forskjell i P/S-forhold

Land